4//SEC Filing
Litchev Boyan Vesselinov 4
Accession 0001493152-22-003030
CIK 0001857044other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 7:08 PM ET
Size
5.5 KB
Accession
0001493152-22-003030
Insider Transaction Report
Form 4
Litchev Boyan Vesselinov
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+90,000→ 90,000 totalExercise: $4.97Exp: 2032-02-01→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on February 1, 2023 and thereafter the remaining shares vest and become exercisable in equal monthly installments over the following 24 months.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001902726
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 7:08 PM ET
- Size
- 5.5 KB